Tempus Stock May Rise on the Acquisition of AI-Driven Deep 6 AI

Tempus AI, Inc. (TEM) recently announced the acquisition of Deep 6 AI, a leading artificial intelligence (AI) company specializing in clinical trial matching. This strategic move aims to enhance Tempus’ precision medicine capabilities by leveraging AI-driven insights to accelerate patient recruitment and improve trial efficiency.With this acquisition, Tempus can further streamline the process of connecting patients with relevant clinical trials, ultimately expediting the development of new treatments. Deep ...